Targeted therapies show initial effectiveness in subset of papillary thyroid cancer
Monday, June 5, 2017 - 13:43
in Health & Medicine
Two immunotherapy drugs currently approved by the US Food and Drug Administration (FDA) for the treatment of melanoma also show promise for treating a rare but aggressive form of papillary thyroid cancer, according to new research.